Jeffrey Kern, MD, is Chief of the New Division of Oncology

Jeffrey Kern, MDPulmonologist Jeffrey Kern, MD, joined National Jewish Health in December 2009 as the leader of the new Division of Oncology. This division is dedicated to the diagnosis, treatment and long-term follow-up and surveillance of individuals with known or suspected lung or thoracic cancers.

Dr. Kern comes to National Jewish Health from Case Western Reserve University, where he was the Chief of Pulmonary, Critical Care and Sleep Medicine, and held the Hubbell Chair in Pulmonary Medicine. He's been a pulmonologist for more than 20 years and has focused intensely on pulmonary oncology. His areas of interest include pulmonary tumorigensis in the lung, (the events within cells that lead to tumor formation) and molecularly targeted pharmacotherapy.

Jeffrey Kern, MD, with patientDr. Kern has experience developing thoracic oncology programs. He helped build nationally recognized programs at both Case Western Reserve University and the University of Iowa. He also served as Vice-Chair of the Respiratory Section of Cancer and Leukemia Group B, a National Cancer Institute funded national clinical trial group focusing on the development and testing of new treatment strategies for lung cancer. He was the founding Chair of the Lung Cancer Translational Science Committee for CALGB and set the basic and translational science research agenda for this national organization.

Dr. Kern earned his MD at the University of Wisconsin, and he completed a fellowship in pulmonary and critical care at the University of Pennsylvania. 

Learn about the Division of Oncology.


Appointments and Questions

1.877.CALL NJH (1.877.225.5654)

Our nurses are available to answer your questions about making an appointment and to discuss care options available at National Jewish Health. Learn more.